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S U M M A R Y
Objectives: Different methods for the classiﬁcation of leprosy have been proposed since the 1930s. The
aim of this study was to compare the current methods at a referral center in Brazil.
Methods: The World Health Organization (WHO) operational classiﬁcation was compared to the Ridley
and Jopling classiﬁcation, the Madrid classiﬁcation, and a classiﬁcation based on the number of body
areas affected by skin and/or neural lesions (NBAA). The correlation between the clinical and
histopathological components of the Ridley and Jopling classiﬁcation was assessed.
Results: The agreement between the WHO operational classiﬁcation and the Ridley and Jopling
classiﬁcation was 77.6% (kappa = 0.53). The WHO operational classiﬁcation tended to overestimate the
number of multibacillary patients. The WHO operational classiﬁcation showed its best agreement with
the NBAA. There was perfect agreement between the clinical and histopathological Ridley and Jopling
classiﬁcation in 46.9% of the patients.
Conclusions: The agreement between the WHO operational classiﬁcation and the Ridley and Jopling
classiﬁcation was better than any other purely clinical classiﬁcation, reinforcing the importance and
simplicity of the operational method. Although major disagreement between the clinical and
histopathological Ridley and Jopling classiﬁcation was uncommon, perfect agreement occurred in less
than half of the cases, and was even lower for the borderline lepromatous and tuberculoid forms.
Possible reasons for the differences are discussed; these showed that there may be room for
improvement in the Ridley and Jopling classiﬁcation histopathological criteria.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Leprosy presents a continuous spectrum of clinical and
pathological manifestations that depend on the type and intensity
of the patient’s immune response to the bacterium Mycobacterium
leprae.1 An intense cellular response is associated with the
containment of the bacillus and to the forms with a paucibacillary
presentation, whose prototype is the tuberculoid form. A primarily
humoral response is associated with intense agent replication and* Corresponding author.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).with multibacillary forms, with the lepromatous form at the
extreme end.2
Several different leprosy classiﬁcations have been proposed since
the 1930s, which consider these two ends of the spectrum and the
intermediate (borderline) manifestations between them.3 Based on
clinical aspects, the Madrid classiﬁcation, from 1953, includes the
tuberculoid (TT), lepromatous (LL), borderline, and indeterminate
(IND) forms. This classiﬁcation was included in the recommenda-
tions of the World Health Organization (WHO) and was prevalent
until 2002.3,4 In 1966, Ridley and Jopling created a classiﬁcation that
is still considered essential for the standardization of leprosy
research. The clinical, pathological, bacilloscopic, and immunologi-
cal criteria of the Ridley and Jopling classiﬁcation provide the basis
for the most complete classiﬁcation of the various forms of theciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Descriptive analysis of 49 new leprosy cases at a
referral center in Minas Gerais, Brazila
Variable n (%)
Sex
Male 27 (55.1)
Female 22 (44.9)
Age, years
<15 2 (4.0)
15–30 12 (24.5)
31–45 10 (20.4)
46–60 13 (26.5)
61–75 12 (24.5)
Number of skin lesions
5 28 (57.1)
>5 21 (42.9)
Number of impaired nervesb
1 41 (83.7)
>1 8 (16.3)
a Source: research data.
b Impaired nerves means thickened or painful
peripheral nerves or sensory or motor functional
impairment in their area of innervation.
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borderline (BB), borderline lepromatous (BL), and LL.5,6
However, while developing multidrug therapy for leprosy, it
became critical for the WHO to establish a simpliﬁed operational
classiﬁcation to differentiate between paucibacillary and multi-
bacillary patients and thus facilitate adequate treatment. Current-
ly, patients are considered paucibacillary if they present up to ﬁve
skin lesions and multibacillary if they present six or more lesions.
This operational classiﬁcation facilitates ﬁeldwork, since it does
not require expertise in assessing skin lesion morphology or
applying the slit-skin smear examination (SSS); however different
studies have indicated its ﬂaws.7–10
On the other hand, studies on the Ridley and Jopling
classiﬁcation have shown great variations in agreement between
its clinical and histopathological components.5,11–18 In a study
conducted in India involving 303 multibacillary patients, 73 of the
178 patients clinically classiﬁed as BT were classiﬁed into a
different leprosy form following the histopathological examina-
tion. The biopsy classiﬁed two of these patients as LL and 32 as IND,
both leprosy forms expected to be easily differentiated from BT.19
The aim of this study was to compare the WHO operational
classiﬁcation with the Ridley and Jopling classiﬁcation at a leprosy
referral center in Brazil. These classiﬁcations were also compared
to the bacilloscopy results (SSS), the Madrid classiﬁcation, and the
NBAA classiﬁcation (number of body areas affected). The latter is
based on the number of body areas affected by skin or neural
lesions.7,20 Finally, the correlation between the clinical and
histopathological components of the Ridley and Jopling classiﬁca-
tion was assessed.
2. Materials and methods
Forty-nine leprosy patients from the leprosy referral clinic of
the Hospital Eduardo de Menezes (Fundac¸a˜o Hospitalar do Estado
de Minas Gerais) agreed to participate and gave their signed
consent.
Patients underwent a complete dermato-neurological exami-
nation by a dermatologist with expertise in leprosy. Skin lesions
were counted and the affected body areas were recorded on the
appropriate form. All patients underwent SSS from four sites (ear
lobes, elbows, and skin lesions). Ziehl–Neelsen staining and SSS
bacilloscopy index assessment were conducted in the same
referral center by an experienced microbiologist. All patients
underwent a skin lesion biopsy. Hematoxylin–eosin and Wade
staining were performed in the Experimental Neuroimmuno-
pathology Laboratory of the Instituto de Cieˆncias Biolo´gicas
(UFMG), where two pathologists with expertise in leprosy
interpreted the histopathological examinations. When there was
divergence between their reports, discussions were held between
the two pathologists at a new session until a consensus diagnosis
was reached.
For the Madrid classiﬁcation, patients with the borderline
and LL forms were considered multibacillary. For the Ridley and
Jopling classiﬁcation, patients with the BB, BL, and LL forms were
considered multibacillary. The histological classiﬁcation was
the one outlined by Ridley.6 For the NBAA classiﬁcation, two
thresholds for the multibacillary status were tested: patients
with two or more body areas involved and patients with three
or more body areas involved. For this purpose, the body surface
was divided into nine areas, as described by Gupta et al. and van
Brakel et al.7,20
To assess the agreement between any two classiﬁcation
methods, 2  2 tables were created and the kappa coefﬁcient
calculated, as well as the percentage of cases in which there was
agreement. Kappa values between 0.20 and 0.40 were considered
‘reasonable’, those between 0.41 and 0.60 were considered‘moderate’, those between 0.61 and 0.80 were considered ‘good’,
and values above 0.81 were considered ‘excellent’. Data were
analyzed using SPSS 15.0 software (SPSS Inc., Chicago, IL, USA).
The discrepancy between the clinical and histopathological
components of the Ridley and Jopling classiﬁcation was classiﬁed
as minimal or major disagreement. Cases in which discrepancy
resulted in a change in the pauci/multibacillary status of the
patient were considered major disagreement. Otherwise, the
disagreement was considered minimal. Histopathological exam-
inations showing non-speciﬁc inﬂammation were diagnosed as
IND to permit the disagreement analysis.
The ﬁnal Ridley and Jopling classiﬁcation included the clinical
presentation, the histopathological ﬁndings, and the SSS results.
3. Results
This study included 49 new leprosy cases. Seventeen (34.7%)
patients had been undergoing treatment for at least 1 day and at
most 30 days; the remaining patients were not undergoing
treatment at the time of inclusion. According to the ﬁnal Ridley and
Jopling classiﬁcation, the incidence of the different leprosy forms
was IND = 9 (18.4%), TT = 5 (10.2%), BT = 21 (42.9%), BB = 1 (2%), BL =
6 (12.2%), and LL = 7 (14.3%). Table 1 presents a descriptive analysis
of the patients.
Twenty-one (42.9%) patients had six or more skin lesions and 16
(32.7%) patients had a positive SSS. Table 2 shows that most
patients were classiﬁed as paucibacillary (with the exception of the
Madrid and NBAA classiﬁcations). When compared to the
operational classiﬁcation, the Madrid and NBAA classiﬁcations
resulted in higher numbers of multibacillary patients, while the
Ridley and Jopling classiﬁcation resulted in a higher percentage of
paucibacillary patients.
The different classiﬁcation systems were compared in terms of
their ability to deﬁne a patient’s multibacillary status. The
operational classiﬁcation was more sensitive for the multibacillary
status diagnosis than the clinical component of the Ridley and
Jopling classiﬁcation alone, but the addition of the histopatholog-
ical examination resulted in a signiﬁcant improvement in the
sensitivity of the Ridley and Jopling classiﬁcation (see Table 2).
When compared with the Ridley and Jopling classiﬁcation, the
Madrid and NBAA classiﬁcations showed lower speciﬁcity for the
multibacillary diagnosis. The purely clinical classiﬁcation system
that best agreed with the Ridley and Jopling classiﬁcation was the
Table 2
Classiﬁcation of 49 new leprosy cases treated at a referral center in the state of Minas Gerais, Brazil, into paucibacillary and multibacillary, according to the following
classiﬁcations: WHO operational, Madrid, NBAA (number of body areas affected), Ridley and Jopling (clinical), Ridley and Jopling (histopathological), and bacilloscopya
Classiﬁcation Paucibacillary Multibacillary MB diagnostic sensitivityb MB diagnostic speciﬁcityb Kappab
n (%) n (%)
Madrid 16 (32.6) 33 (67.3) 100% 51.6% 0.44
NBAA (two or more areas) 13 (26.5) 36 (73.5) 100% 41,9% 0.35
NBAA (three or more areas) 25 (51.0) 24 (49) 83.3% 71.0% 0.51
Operational 28 (57.1) 21 (42.9) 77.8% 77.4% 0.53
Ridley and Jopling (clinical) 37 (75.5) 12 (24.5) 66.7% 100% 0.72
Ridley and Jopling (histopathological) 33 (67.3) 16 (32.7) 88.9% 100% 0.91
Bacilloscopy (SSS)c 32 (65.3) 16 (32.7) 84% 100% 0.87
WHO, World Health Organization; MB, multibacillary; SSS, slit-skin smear examination.
a Source: research data.
b The sensitivity and speciﬁcity measures, as well as kappa, were calculated based on the ﬁnal Ridley and Jopling classiﬁcation.
c One patient did not have skin smear data.
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= 0.53).
The agreement between the Ridley and Jopling classiﬁcation
and the WHO operational classiﬁcation was 77.6% (Table 3). One-
third of the patients considered multibacillary by the operational
classiﬁcation were classiﬁed as paucibacillary by the Ridley and
Jopling classiﬁcation. On the other hand, four (14.3%) of the
28 patients considered paucibacillary by the operational classiﬁ-
cation were considered multibacillary by the Ridley and Jopling
classiﬁcation.
Bacilloscopy (SSS) classiﬁed as multibacillary four of the 27
(14.8%) patients considered paucibacillary by the operational
classiﬁcation. Moreover, the SSS classiﬁed as paucibacillary nine of
21 (42.8%) patients considered multibacillary by the operational
classiﬁcation (Table 3).
The best agreement with the WHO operational classiﬁcation
was obtained by the NBAA classiﬁcation with three or more areas
(93.8%, kappa = 0.88) and the lowest agreement was observed for
NBAA classiﬁcation with two or more areas (69.4%, kappa = 0.43).
There was perfect agreement between the Ridley and Jopling
clinical and histopathological classiﬁcations in 23 cases (46.9%).Table 3
Agreement between the WHO operational classiﬁcation and the other classiﬁcation meth
Brazila
Madrid NBAA 2 
Multi Pauci Multi Pauci 
WHO operational
classiﬁcation
Multi 21
(42.8%)
0
(0%)
21
(42.8%)
0
(0%)
Pauci 12
(24.5%)
16
(32.6%)
15
(30.6%)
13
(26.5%)
Agreement: 75.5% Agreement: 69.4% 
Kappa: 0.53 Kappa: 0.43 
WHO, World Health Organization; NBAA, number of body areas affected; SSS, slit-skin
a Source: research data.
Table 4
The discrepancy between the clinical and histopathological components of the Ridley and
of Minas Gerais, Brazila
Ridley and Jopling histopathological classiﬁcation n Perfec
Indeterminate 11 8 (72
Tuberculoid 7 2 (28
Borderline tuberculoid 12 6 (50
Mid-borderline 0 - 
Borderline lepromatous 7 1 (14
Lepromatous 7 6 (85
Non-speciﬁc 5 0 
a Source: research data.The best agreement occurred in the LL form (85.7%), followed by
the IND (72.7%) and BT (50%) forms. Clinical and histopathological
diagnoses were in agreement in only 28.6% of TT cases and 14.3% of
BL cases (Table 4). There was minor disagreement between the
histopathological and clinical proﬁles in 20 cases (40.8% of the
sample).
As seen in Table 4, four (80%) of the ﬁve cases considered non-
speciﬁc inﬂammation by the histopathological examination and
classiﬁed as IND for the purposes of the disagreement analysis had
minor disagreement with the clinical hypothesis. Their pauciba-
cillary status was not altered, since all four were clinically
classiﬁed as BT. In the major disagreement case, the clinical
classiﬁcation was the BB form.
Except for this last case, major disagreement was seen only in
cases classiﬁed as BL by the histopathological examination. Of the
seven cases classiﬁed as BL in biopsies, ﬁve (71.4%) were ﬁrst
clinically misclassiﬁed as BT (Table 5).
In six cases, the disagreement occurred between the clinical BT
classiﬁcation and the IND/non-speciﬁc histopathological inﬂam-
mation. Of these, four presented multiple hypopigmented macules
and one had slightly elevated plaque lesions, all very suggestive ofods in 49 new leprosy cases treated at a referral center in the state of Minas Gerais,
NBAA 3 SSS Ridley and Jopling
Multi Pauci Multi Pauci Multi Pauci
21
(42.8%)
0
(0%)
12
(25%)
9
(18.7%)
14
(28.6%)
7
(14.3%)
3
(6.1%)
25
(51%)
4
(8.3%)
23
(47.9%)
4
(8.2%)
24
(49.0%)
Agreement: 93.8% Agreement: 72.9% Agreement: 77.6%
Kappa: 0.88 Kappa: 0.43 Kappa: 0.53
 smear bacilloscopy; Multi, multibacillary; Pauci, paucibacillary.
 Jopling classiﬁcation in 49 new leprosy cases treated at a referral center in the state
t agreement Minor disagreement Major disagreement
.7%) 3 (27.3%) 0
.6%) 5 (71.4%) 0
%) 6 (50%) 0
- -
.3%) 1 (14.3%) 5 (71.4%)
.7%) 1 (14.3%) 0
4 (80%) 1 (20%)
Table 5
Correlation between the clinical and histopathological components of the Ridley and Jopling classiﬁcation methods in 49 new leprosy cases treated at a referral center in the
state of Minas Gerais, Brazila
Ridley and Jopling histopathological classiﬁcation (n)
TT BT BB BL LL Indeterminate Non-speciﬁc Total
Ridley and Jopling clinical classiﬁcation
(n)
TT 2 3 0 0 0 1 0 6
BT 5 6 0 5 0 2 4 22
BB 0 1 0 1 0 0 1 3
BL 0 0 0 1 1 0 0 2
LL 0 0 0 0 6 0 0 6
Indeterminate 0 2 0 0 0 8 0 10
Total 7 12 0 7 7 11 5 49
TT, tuberculoid; BT, borderline-tuberculoid; BB, mid-borderline; BL, borderline-lepromatous; LL, lepromatous.
a Source: research data.
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clinical classiﬁcation was IND while the histopathological classiﬁ-
cation was BT. Both patients presented single hypopigmented
macular lesions and negative SSS, and their histopathological
ﬁndings were, therefore, surprising.
Three cases were clinically considered TT and were classiﬁed as
BT by the histopathological examination. Two of these presented
single erythematous plaques and the third patient had two
erythematous plaques located in different body areas. Five patients
clinically classiﬁed as BT were classiﬁed as TT following the biopsy
report. Supporting the BT clinical diagnosis, two of these presented
multiple erythematous plaques (six and eight) and four presented
lesions spread across three or more areas of the body.
4. Discussion
The convenience sampling method explains the small number
of patients in this study. Studies with small samples should prompt
further research, preferably international multicenter studies.
Nonetheless, the convenience character of the sample enabled the
researchers to control and participate in the whole process of
diagnosis conﬁrmation, lesion counting, morphological descrip-
tion of the lesions, and the conﬁrmation of clinical improvement
during treatment. This scientiﬁc approach to the recruitment and
inclusion process would be more difﬁcult if only retrospective
medical records or tissue bank materials in the laboratory were
analyzed.
The agreement between the WHO operational classiﬁcation and
the Ridley and Jopling classiﬁcation was moderate (kappa = 0.53).
The operational classiﬁcation overestimated the number of
multibacillary patients (42.9% vs. 36.8%) and classiﬁed as
paucibacillary 28.6% of the patients considered multibacillary by
the Ridley and Jopling classiﬁcation. In a survey of 264 patients in
the Philippines, 31–58% of cases considered multibacillary by SSS
or skin biopsy had fewer than six skin lesions.9 In a Brazilian study,
conducted in the state of Sergipe with records from 1213 patients,
11% of cases who had fewer than six skin lesions had positive SSS
smears.8
The moderate kappa value and the agreement in 77.6% of the
cases compared to the Ridley and Jopling classiﬁcation conﬁrm
the importance of the operational classiﬁcation, and its undeniable
simplicity of implementation in the ﬁeld is reinforced. The
operational classiﬁcation obtained the best agreement with
the Ridley and Jopling classiﬁcation when compared with any
other purely clinical classiﬁcation method.
The NBAA classiﬁcation showed good sensitivity for the
multibacillary status diagnosis, even better than the operational
classiﬁcation. One possible explanation for this is that the degree of
dispersion of the lesions along the skin’s surface may add
information about the multibacillary status, beyond the simplelesion count. In this sense, the NBAA classiﬁcation takes into
account not only the presence of skin lesions, but also neurological
involvement. Skin lesions concomitant with neuropathies in
different body areas are clinically more suggestive of multi-
bacillary cases.2
Performing the NBAA classiﬁcation requires training in the
neurological examination of peripheral nerves. Besides, the NBAA
classiﬁcation showed lower speciﬁcity values for the multi-
bacillary status diagnosis than the operational classiﬁcation. In a
Nepalese study involving 756 patients, the sensitivity and
speciﬁcity of the NBAA classiﬁcation (three or more areas)
compared to the SSS and histopathological examination were
93% and 39%, respectively.20 In another study with 100 patients in
India, the NBAA rating (two or more areas) had better sensitivity
(90% vs. 63%) but lower speciﬁcity (75% vs. 85%) than the
operational WHO classiﬁcation.7
In Brazil, the current recommendation on SSS comes in the form
of a government speciﬁcation. According to this, health care
workers, whenever possible, should perform SSS to help classifying
leprosy patients. Although the operational classiﬁcation is still the
recommended method, any positive SSS result, regardless of its
semi-quantitative logarithmic value, classiﬁes the patient as
multibacillary. That speciﬁcation does not take into account
negative results. In this way, the positive SSS, a simple and
inexpensive laboratory test, can undoubtedly improve the
sensitivity of the operational classiﬁcation for the detection of
multibacillary cases.
Regarding the Ridley and Jopling classiﬁcation, a complete
agreement between its clinical and histopathological components
occurred in only 46.9% of cases. The creators of the Ridley and
Jopling classiﬁcation obtained complete agreement in only 68% of
the 82 cases studied.5 Meyers et al. studied 1429 patients and
reported complete agreement in 77.2% of cases, but their results
were reported only in part in congress proceedings.21 Sehgal et al.
studied 82 patients and reported perfect agreement in only 42.7%
of cases.14
The best clinicopathological correlation was seen for the LL
form (85.7%), followed by the IND form (72.7%), similar to reports
from other authors.10,13,16,17 Agreement was lowest for the BL form
(14.3%), for which other authors have reported agreement rates
between 43% and 70%.13,14,16,17,19 In this sample, the disagree-
ments involving histopathological diagnosis of BL occurred
together with a clinical diagnosis of BT (ﬁve of the seven
discordant cases). Likewise, Lockwood et al. (2012) studied
303 cases of multibacillary leprosy and reported that 41% of
patients with the clinical BT form were reclassiﬁed following the
histopathological examination, with nearly a third of them being
reclassiﬁed as BL.19
Different factors explain the clinicopathological disagreement
between the BT and BL forms. First, the distinction between these
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reference center receives more patients with greater diagnostic
difﬁculty and it is possible that this sample had a bias towards less
typical clinical presentations. Second, discordant results between
these two forms may simply represent the natural immune
instability of leprosy, with consequent clinicopathological dis-
sociations becoming evident during research.17,19 Third, although
detailed and speciﬁc, it appears that the Ridley and Jopling
histopathological criteria are not always easy to implement. In
some cases, it is very difﬁcult to differentiate between an inﬁltrate
made up mostly of macrophages with small lipid vesicles and one
mostly containing poorly differentiated epithelioid cells.
The clinicopathological correlation of the TT form was also low
(28.6%). Among clinically tuberculoid cases, there were more cases
classiﬁed as BT than conﬁrmed as TT by pathology. Conversely, ﬁve
of the 22 cases clinically classiﬁed as BT were classiﬁed as TT by
the pathologist. Manandhar et al. had histological conﬁrmation in
only six of 25 patients clinically classiﬁed as TT, while 13 were
reclassiﬁed as BT.11 Bhatia et al. studied 1272 patients and, upon
observing similar clinicopathological discordances, suggested that
the line separating the TT and BT forms in biopsies is uncertain and
that the current histopathological criteria of the Ridley and Jopling
classiﬁcation may not be appropriate.13
One should highlight the group of patients clinically classiﬁed
as BT but with histopathological diagnosis of IND or non-speciﬁc
inﬂammation. Of these six cases, four had multiple hypopigmented
macules and therefore should not be considered IND. There is little
information about this particular group of ‘BT-macular’ patients in
the literature. In many cases, a peripheral nerve biopsy is
consistent with the clinical presentation, despite the non-speciﬁc
skin biopsy.15
It is interesting to note the absence of cases classiﬁed as BB by
the histopathological examination among these 49 patients. None
of the three patients clinically classiﬁed as such was conﬁrmed
by biopsy. This is an uncommon form, but it is worth mentioning
that the BB form was also absent among the pathology reports
of 303 multibacillary patients from the INFIR cohort (ILEP –
International Federation of Anti-Leprosy Associations – Nerve
Function Impairment in Reaction), included in studies that focused
on leprosy reaction predictors and the associated neurological
deﬁcits.19 In another study, in which three experienced dermato-
pathologists examined biopsies from 100 patients in Malawi, the
BB form was found only once during the ﬁrst round of biopsy
interpretation, and the same examiner did not identify the BB form
again on the second blind round of interpretation.22 According to
Ridley (1974), the histopathological difference between the BT and
BB forms resides mainly in the estimate of the number of
lymphocytes that permeate the epithelioid inﬂammatory inﬁl-
trate. In the BT form, there is a moderate lymphocytic inﬁltrate,
while it is scarce in the BB form.6 It could be hypothesized that
the lack of BB forms in pathological reports may arise from the
fact that this ‘scarce’ description might be unduly subjective.
In conclusion, the agreement between the WHO operational
classiﬁcation and the Ridley and Jopling classiﬁcation was
moderate and better than any other purely clinical classiﬁcation
studied. However, it should be a concern that the operational
classiﬁcation may result in an insufﬁcient treatment regimen for
many of the multibacillary cases. Although major disagreement
between the clinical and histopathological components of the
Ridley and Jopling classiﬁcation was uncommon, perfect agree-
ment between these components occurred in less than half of the
cases, and was even lower for the BL and TT forms. This shows
that there is room for improvement in the Ridley and Joplingclassiﬁcation, especially in some of its histopathological criteria.
Leprosy is a complex disease and patients deserve a better
standard of care, including more reliable and accurate classiﬁca-
tion methods to avoid misclassiﬁcations.
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